At present there are no real therapies able to improve visual performance in patients with age-related macular degeneration, atrophic type. The aim of the study is to verify whether with rehabilitation sessions with Retimax Vision Trainer it is possible to teach the maculopathic patient to exploit the extrafoveal areas of the retina, not affected by atrophy, resorting to an eccentric vision that compensates for the foveal one, thus obtaining a improvement of visual outcomes (far and near vision capacity, sensitivity to contrast to reading, reading speed, fixation capacity and overall quality of life of the visually impaired patient suffering from atrophic senile maculopathy (AMD)). To do this, the study design was conceived as a non-randomized prospective comparative and involves the formation of two groups of patients: a group A of 15 patients who will be rehabilitated with Retimax and a group B of 15 patients who will not be rehabilitated, but only re-evaluated at the same distance of time that will elapse for group A. Eligible patients are affected by atrophic AMD with unstable fixation and better vision in the eye between 1/10 and 4/10 in the absence of other serious eye diseases. As there is currently no real therapy capable of improving visual performance, the demonstration of the positive effect of the visual rehabilitation program with Retimax in patients suffering from atrophic macular degeneration may encourage a wider use of this method. The patient could benefit from a non-invasive, repeatable and cost-effective procedure.
Age range
18 Years – 90 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Change in Far Visual Acuity pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Contrast Sensitivity pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Near Visual Acuity pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Reading Speed pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Score in the Questionnaire "Quality of Life" pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Retinal sensitivity to microperimetry pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Fixation in the 2 central degrees pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops
Change in Fixation in the 4 central degrees pre and post treatment
Timeframe: one week before the treatment starts and one week after the treatment stops